The trial revealed that Ozempic® 1 mg significantly lowered the relative risk of worsening kidney disease, kidney failure, and cardiovascular death by 24% compared to a placebo, in addition to ...

Microdosing GLP-1 has been touted for everything for weight management to perimenopause symptoms. But is it all it’s cracked ...

Wegovy. Zepbound… and yes, Ozempic. A Kaiser Family Foundation poll found that one in 8 American adults reported trying a GLP-1 medication. “Body by Ozempic” has become a punchline on red ...

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

He says, "we now have two successful ways to combat obesity-GLP-1 agonist drugs (like Ozempic) and bariatric surgery." But is bariatric surgery better than Ozempic? "Bariatric surgery has evolved ...

About 215,000 used GLP-1 drugs, while the rest were taking various other diabetes medications. Though semaglutides like Ozempic and Wegovy dominate the market in the U.S., Al-Aly and his team ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...

Conagra and General Mills are among the food companies offering special options for people on GLP-1 drugs, but the products ...

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive ...

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.